Advanced Internal Medicine of Michiana (AIM) logo
HybridInternal Medicine

Advanced Internal Medicine of Michiana (AIM)

Quick Facts

Membership Price RangeCompetitive pricing with flexible payment options available.
Practice TypeHybrid
LocationMishawaka, Michiana
DoctorsDahan Al-Fadhl PhD, MD, Internal Medicine

About

At Advanced Internal Medicine of Michiana (AIM), Dr. Dahan Al-Fadhl leads comprehensive care for adults in Mishawaka, Indiana. The practice carries over 20 years of experience managing adult health across a wide range of conditions. Board-certified physicians and nurse practitioners guide every service. AIM blends internal medicine with an expanding wellness center. The practice manages chronic conditions like diabetes, hypertension, heart disease, COPD, and autoimmune disorders. It also offers MLS laser therapy through the OrthoLazer® system, medically supervised weight loss, and NAD+ rejuvenation services. The AIM+ Concierge Medicine program gives members direct physician access, executive physicals, longer appointments, and discounted labs. Every therapy and treatment plan integrates into a broader medical framework built on evidence-based care and patient safety.

Details

Address

3809 N Main St, Suite 100, Mishawaka, IN 46545

Membership Details

Competitive pricing with flexible payment options available for AIM+ Concierge Medicine.

Our Doctors

Similar Practices Nearby

Explore More

Frequently Asked Questions

AIM offers a broad range of adult health services including internal medicine, the AIM+ Concierge Medicine program, medically supervised weight loss, MLS laser therapy, NAD+ rejuvenation, wellness checks, heart and vascular services, diabetic management, medication management, blood pressure monitoring, blood draws, immunizations, sick visits, executive physicals, and pain management.

AIM+ Concierge Medicine gives members direct physician access, a dedicated concierge line, executive physicals, longer appointments, discounted labs, and flexible scheduling. The practice offers competitive pricing with flexible payment options for the program.

Yes. AIM's weight loss program pairs physician oversight with lifestyle support and medication when appropriate. Physicians review each patient's full medical history and current medications before recommending any treatment. The program focuses on safe, sustainable results rather than quick fixes.

AIM offers MLS laser therapy using the OrthoLazer® system. This non-invasive treatment combines continuous and pulsed light energy to address both pain and inflammation simultaneously. It involves no injections, surgery, or medications. Physicians integrate it into broader care plans rather than offering it as a standalone service.

AIM's physicians manage diabetes, hypertension, heart disease, COPD, autoimmune disorders, and complex multi-condition cases. The practice provides ongoing monitoring, personalized treatment plans, and regular follow-ups to support long-term stability.

NAD+ injections support cellular energy production and healthy aging. At AIM, physicians administer them under medical supervision as part of a structured longevity plan. The practice evaluates each patient's health profile, medications, and metabolic factors before recommending the therapy.

Dr. Dahan Al-Fadhl, a board-certified internal medicine physician with an MD and PhD, leads care at AIM. Nurse practitioners also support the clinical team. Every service receives oversight from board-certified physicians.

Prospective patients can request an appointment or schedule a consultation through the AIM website. The team reaches out to discuss health goals and identify the most appropriate services. AIM serves adult patients at 3809 N Main St Suite 100, Mishawaka, IN 46545.

Yes. AIM uses the athenahealth patient portal for secure communication and health management between visits.

AIM focuses exclusively on adult patients. The practice delivers care across every stage of adult health, from routine wellness visits to complex chronic disease management.

Practice last updated June 11, 2026